Gelonghui March 14 | Jinhe Biotech (002688.SZ) said on the investor interactive platform that the company's project with an annual output of 1,000 tons of doxycycline hydrochloride has now been put into operation. The treatment of doxycycline hydrochloride complements the prevention of quinomycin, enriches the company's product system, and can provide better solutions for downstream customers.
金河生物(002688.SZ)：公司年产1000吨盐酸多西环素项目现已投产
Jinhe Biology (002688.SZ): The company's project with an annual output of 1000 tons of doxycycline hydrochloride has now been put into operation
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.